Drug Shortage Report for TEVA-TELMISARTAN HCTZ
Report ID | 99952 |
Drug Identification Number | 02330288 |
Brand name | TEVA-TELMISARTAN HCTZ |
Common or Proper name | TELMISARTAN/HCTZ 80/12.5MG TABS |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | HYDROCHLOROTHIAZIDE TELMISARTAN |
Strength(s) | 12.5MG 80MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 500 & 100's |
ATC code | C09DA |
ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-11-28 |
Estimated end date | |
Actual end date | 2022-01-05 |
Shortage status | Resolved |
Updated date | 2022-01-07 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v26 | 2022-01-07 | French | Compare |
v25 | 2022-01-07 | English | Compare |
v24 | 2021-10-14 | French | Compare |
v23 | 2021-10-14 | English | Compare |
v22 | 2021-02-25 | French | Compare |
v21 | 2021-02-25 | English | Compare |
v20 | 2020-07-16 | French | Compare |
v19 | 2020-07-16 | English | Compare |
v18 | 2020-05-21 | French | Compare |
v17 | 2020-05-21 | English | Compare |
v16 | 2020-05-14 | French | Compare |
v15 | 2020-05-14 | English | Compare |
v14 | 2020-05-08 | French | Compare |
v13 | 2020-05-08 | English | Compare |
v12 | 2020-05-08 | French | Compare |
v11 | 2020-05-08 | English | Compare |
v10 | 2020-04-10 | French | Compare |
v9 | 2020-04-10 | English | Compare |
v8 | 2020-04-09 | French | Compare |
v7 | 2020-04-09 | English | Compare |